Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03927508 · ClinicalTrials.gov registry record · Phase 1
First - In - Man Study to Assess the Safety and Feasibility of The Bashir™ Endovascular Catheter for the Treatment of Acute Pulmonary Embolism
A Phase 1 study of Pulmonary Embolism, sponsored by Thrombolex.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
- 5
- Study locations
NCT03927508 is a Phase 1 study of Pulmonary Embolism that has completed, run by Thrombolex. The registered enrollment target is 9 participants, below the 3,058-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (100% lower). The trial reports 5 study locations across 4 states.
The verdict
NCT03927508, a Phase 1 study of Pulmonary Embolism, has completed, sponsored by Thrombolex.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
- 5
- Study locations
Study Summary
The Bashir™ Endovascular Catheter is a device intended for the localized infusion of therapeutic agents into the pulmonary artery and peripheral vasculature.
Conditions Studied
Interventions
- DRUG r-tPA
- DEVICE The Bashir™ Endovascular Catheter
Study Locations (5)
Pennsylvania
- University Pittsburg Medical Center - Hamot - Erie
- Temple University Hospital - Philadelphia
Florida
- Advent Health Orlando - Orlando
Indiana
- St Vincent Hospital and Health Care Center, Inc. - Indianapolis
New York
- Columbia University Medical Center - Presbyterian - New York - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-03-14 |
| Est. Completion | 2020-01-23 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03927508
The ClinicalTrials.gov registry entry for NCT03927508 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,058-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (100% lower). The listed sponsor is Thrombolex, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pulmonary Embolism appearing as the primary indexed condition, and to 2 interventions - of which r-tPA is the first listed.
NCT03927508 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Pennsylvania, Florida, Indiana.
Frequently Asked Questions
What is clinical trial NCT03927508 about?
NCT03927508 is a clinical study titled "First - In - Man Study to Assess the Safety and Feasibility of The Bashir™ Endovascular Catheter for the Treatment of Acute Pulmonary Embolism". The Bashir™ Endovascular Catheter is a device intended for the localized infusion of therapeutic agents into the pulmonary artery and peripheral vasculature.
What is the current status of trial NCT03927508?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2019-03-14. Estimated completion is 2020-01-23.
What conditions does trial NCT03927508 study?
This clinical trial studies the following conditions: Pulmonary Embolism.
What interventions are being tested in trial NCT03927508?
The interventions under investigation include: r-tPA (DRUG), The Bashir™ Endovascular Catheter (DEVICE).
Who is sponsoring clinical trial NCT03927508?
This trial is sponsored by Thrombolex, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03927508 being conducted?
This trial has 5 study locations across Florida, Indiana, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Embolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase I Trial of Inhaled Nitric Oxide to Treat Acute Pulmonary Embolism
COMPLETED · Phase 1
-
A Study of Mobility Outcomes in Post-Pulmonary Embolic Disease
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
The PERSEVERE Study
RECRUITING · NA
-
Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.